Mark Tyndall

Business address
1101 Q St Nw, Washington, DC, 20009
Top holdings (ownership)
Keenova Therapeutics plc
Get insider transactions for this reporting owner
Mark Tyndall has filed 10 SEC EDGAR filings since 29 Aug 2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing OWNERSHIP DOCUMENT 05 Jan 2026 01 Jan 2026 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 04 Aug 2025 31 Jul 2025 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 02 Jan 2025 01 Jan 2025 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 06 Feb 2024 02 Feb 2024 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 16 Nov 2023 14 Nov 2023 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 18 Aug 2023 17 Aug 2023 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 05 Jul 2023 30 Jun 2023 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 05 Apr 2023 03 Apr 2023 001-35803
4 Open Document Open Filing OWNERSHIP DOCUMENT 22 Dec 2022 14 Dec 2022 001-35803
3 Open Document Open Filing OWNERSHIP DOCUMENT 29 Aug 2022 17 Aug 2022 001-35803